Company: LIMN
Filing Date: 2025-01-27
Form Type: POS AM
Source: 0001104659-25-006325
Chunk: 380

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-27
Form: POS AM
Chunk 380
---
 it will cease paying these monthly fees. In addition, Sponsor, executive officers and directors, or any of their respective affiliates are reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. Our audit committee reviews on a quarterly basis all payments that were made to the Sponsor, executive officers or directors, or our or their affiliates. Any such payments prior to an initial business combination will be made from funds held outside the Trust Account. Other than quarterly audit committee review of such reimbursements, we do not expect to have any additional controls in place governing our reimbursement payments to our directors and executive officers for their out-of-pocket expenses incurred in connection with our activities on our behalf in connection with identifying and consummating an initial business combination. Other than these payments and reimbursements, no compensation of any kind, including finder’s and consulting fees, is paid by Iris to the Sponsor, executive officers and directors, or any of their respective affiliates, prior to completion of the Business Combination.

It is possible that some or all of our executive officers and directors may negotiate employment or consulting arrangements to remain with ParentCo after the Business Combination. The existence or terms of any such employment or consulting arrangements to retain their positions with us may influence our management’s motivation proceeding with the Business Combination, but we do not believe that this will be a determining factor in our decision to proceed with the Business Combination. We are not party to any agreements with our executive officers and directors that provide for benefits upon termination of employment. For more information about the interests of Sponsor, directors and officers in the Business Combination, see the section titled “ Proposal No. 1 — The Business Combination Proposal — Interests of Certain Persons in the Business Combination. ”

<div align='center'>206</div>

TABLE OF CONTENTS

MANAGEMENT OF PARENTCO FOLLOWING THE BUSINESS COMBINATION The following sets forth certain information, as of January 2, 2025, concerning the persons who are expected to serve as directors and executive officers of ParentCo following the consummation of the Business Combination and assuming the election of the nominees at the Special Meeting as set forth in “ Election of Directors Proposal ”.

| Name                           | ​ | ​ | Age | ​ | ​ | Position                             | ​ |
| Chris Kim                      | ​ | ​ |  65 | ​ | ​ | Chief Executive Officer and Director | ​ |
| Scott Dam                      | ​ | ​ |  45 | ​ | ​ | Chief